Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Claim Costs Industry Data

NCCI Publishes Mega Claims Report

Mega claims – with losses over $2 million – represent less than 0.1% of claims, but over 2% of total loss dollars.

February 10, 2025

Claim Costs Industry Data

NCCI Releases Medical Inflation Report

The report the rising cost of physician services, the largest category of medical spending in workers’ comp.

February 10, 2025

Kansas Introduces Provider Choice Bill

Injured workers would be allowed to select their provider, and language allowing regulators to select new providers would be removed.

February 10, 2025

Alternative Therapy

New Mexico, New York, & Oregon Consider Chiropractor and Acupuncturist Bills

These bills would grant more authority to these practitioners, in one case letting them prescribe and administer prescription drugs.

February 10, 2025

WCRI Reports on Changes in The Medical Workforce

The provider shortage increased during the pandemic, but a shift to advanced practitioners saw minimal impacts to claims costs and other metrics.

February 3, 2025

Ketamine Therapy Bills in Hawaii, Missouri, & Texas

Hawaii considers partial coverage, Missouri wants stricter guidelines, & Texas proposes a grant program for military and first responders.

February 3, 2025

Florida Bills Could Clarify Heart Disease Presumption for First Responders

Statutes from 1965 did not define what constitutes “heart disease” and these new bills would provide definitions that expand the presumption.

February 3, 2025

Marijuana Bills in Massachusetts, Nebraska, and South Dakota

Massachusetts is considering reimbursement, Nebraska works on medical use, and South Dakota considers revoking medical use.

February 3, 2025

NCCI Publishes Labor Market Insight Report

The report covers trend in employment growth, wages, and sectors most impacted.

January 27, 2025

« Previous 1 … 41 42 43 44 45 … 56 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

regulatory recap newsletter image

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

4 Regulatory Trends to Watch Out for in 2020

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.

Marijuana Bills Could Create Protections for Employment Discrimination

Testing positive for marijuana use could one day no longer prohibit employment.

An Opioid Snapshot for 2020

With a flurry of opioid developments lately, what does the big picture look like?

Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

« Previous 1 … 41 42 43 44 45 … 51 Next »

Back to Top

Workers' Comp Property and Casualty PBM
Expires 01/01/2028